Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients.
Haneya A A AnaniAmany M TawfeikSoheir S MakladAbeer M KamelEnas E El-SaidAsmaa S FaragPublished in: Psoriasis (Auckland, N.Z.) (2020)
The level of circulating CFD could be used to monitor psoriasis severity. However, its level cannot be stated for the treatment, except in severe erythrodermic patients upon successful treatment with methotrexate. We recommend validation of a convenient and accurate DNA assay applied directly to biological samples which does not require prior DNA extraction and amplification.